Steroid-Refractory Immune-Related Adverse Events Induced by Checkpoint Inhibitors

SIMPLE SUMMARY: With the common use of immune checkpoint inhibitors (ICIs) as a standard therapy for many tumor entities, the number of immune-related adverse events (irAEs) has increased. Side effect management for irAEs includes the administration of corticosteroids which are mostly very effective...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomsitz, Dirk, Ruf, Theresa, Zierold, Sarah, French, Lars E., Heinzerling, Lucie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177379/
https://www.ncbi.nlm.nih.gov/pubmed/37174003
http://dx.doi.org/10.3390/cancers15092538

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177379/
https://www.ncbi.nlm.nih.gov/pubmed/37174003
http://dx.doi.org/10.3390/cancers15092538

Ejemplares similares